Literature DB >> 33469541

Combating COVID-19 With Mesenchymal Stem/Stromal Cell Therapy: Promise and Challenges.

Shihua H Wang1, Ashok K Shetty2, Kunlin Jin3, Robert Chunhua Zhao1,4.   

Abstract

Entities:  

Keywords:  COVID-19; exosome; extracellular vesicle; mesenchymal stem cell; therapy

Year:  2021        PMID： 33469541      PMCID： PMC7813676          DOI： 10.3389/fcell.2020.627414

Source DB:  PubMed          Journal:  Front Cell Dev Biol        ISSN： 2296-634X


× No keyword cloud information.
  18 in total

1.  Chromatographically isolated CD63+CD81+ extracellular vesicles from mesenchymal stromal cells rescue cognitive impairments after TBI.

Authors:  Dong-ki Kim; Hidetaka Nishida; Su Yeon An; Ashok K Shetty; Thomas J Bartosh; Darwin J Prockop
Journal:  Proc Natl Acad Sci U S A       Date:  2015-12-22       Impact factor: 11.205

2.  Is the intravascular administration of mesenchymal stem cells safe? Mesenchymal stem cells and intravital microscopy.

Authors:  Dario Furlani; Murat Ugurlucan; LeeLee Ong; Karen Bieback; Erik Pittermann; Ingeborg Westien; Weiwei Wang; Can Yerebakan; Wenzhong Li; Ralf Gaebel; Ren-ke Li; Brigitte Vollmar; Gustav Steinhoff; Nan Ma
Journal:  Microvasc Res       Date:  2009-02-26       Impact factor: 3.514

Review 3.  Regulation of immune responses by extracellular vesicles.

Authors:  Paul D Robbins; Adrian E Morelli
Journal:  Nat Rev Immunol       Date:  2014-03       Impact factor: 53.106

Review 4.  Concise Review: MSC-Derived Exosomes for Cell-Free Therapy.

Authors:  Donald G Phinney; Mark F Pittenger
Journal:  Stem Cells       Date:  2017-03-10       Impact factor: 6.277

Review 5.  The biology, function, and biomedical applications of exosomes.

Authors:  Raghu Kalluri; Valerie S LeBleu
Journal:  Science       Date:  2020-02-07       Impact factor: 47.728

Review 6.  Stem cells in the treatment of diabetes mellitus - Focus on mesenchymal stem cells.

Authors:  Günter Päth; Nikolaos Perakakis; Christos S Mantzoros; Jochen Seufert
Journal:  Metabolism       Date:  2018-10-18       Impact factor: 8.694

7.  Exosomes Derived from Bone Marrow Mesenchymal Stem Cells as Treatment for Severe COVID-19.

Authors:  Vikram Sengupta; Sascha Sengupta; Angel Lazo; Peter Woods; Anna Nolan; Nicholas Bremer
Journal:  Stem Cells Dev       Date:  2020-05-12       Impact factor: 3.272

8.  Mesenchymal stromal cells as treatment or prophylaxis for acute or chronic graft-versus-host disease in haematopoietic stem cell transplant (HSCT) recipients with a haematological condition.

Authors:  Sheila A Fisher; Antony Cutler; Carolyn Doree; Susan J Brunskill; Simon J Stanworth; Cristina Navarrete; John Girdlestone
Journal:  Cochrane Database Syst Rev       Date:  2019-01-30

9.  Transplantation of ACE2- Mesenchymal Stem Cells Improves the Outcome of Patients with COVID-19 Pneumonia.

Authors:  Zikuan Leng; Rongjia Zhu; Wei Hou; Yingmei Feng; Yanlei Yang; Qin Han; Guangliang Shan; Fanyan Meng; Dongshu Du; Shihua Wang; Junfen Fan; Wenjing Wang; Luchan Deng; Hongbo Shi; Hongjun Li; Zhongjie Hu; Fengchun Zhang; Jinming Gao; Hongjian Liu; Xiaoxia Li; Yangyang Zhao; Kan Yin; Xijing He; Zhengchao Gao; Yibin Wang; Bo Yang; Ronghua Jin; Ilia Stambler; Lee Wei Lim; Huanxing Su; Alexey Moskalev; Antonio Cano; Sasanka Chakrabarti; Kyung-Jin Min; Georgina Ellison-Hughes; Calogero Caruso; Kunlin Jin; Robert Chunhua Zhao
Journal:  Aging Dis       Date:  2020-03-09       Impact factor: 6.745

10.  Preying on Public Fears and Anxieties in a Pandemic: Businesses Selling Unproven and Unlicensed "Stem Cell Treatments" for COVID-19.

Authors:  Leigh Turner
Journal:  Cell Stem Cell       Date:  2020-05-07       Impact factor: 24.633
View more
  8 in total

Review 1.  Molecular and Clinical Aspects of COVID-19 Vaccines and Other Therapeutic Interventions Apropos Emerging Variants of Concern.

Authors:  Khursheed Ul Islam; Thoraya Mohamed Elhassan A-Elgadir; Sarah Afaq; Tanveer Ahmad; Jawed Iqbal
Journal:  Front Pharmacol       Date:  2021-12-23       Impact factor: 5.810

Review 2.  COVID-19 immunotherapy: Treatment based on the immune cell-mediated approaches.

Authors:  Mahdi Zavvar; Aisan Yahyapoor; Hamed Baghdadi; Sina Zargaran; Sara Assadiasl; Kamal Abdolmohammadi; Amir Hossein Abooei; Mohammad Reza Sattarian; Melina JalaliFarahani; Negar Zarei; Amirali Farahvash; Yousef Fatahi; Gunnur Deniz; Mitra Zarebavani; Mohammad Hossein Nicknam
Journal:  Int Immunopharmacol       Date:  2022-02-25       Impact factor: 5.714

Review 3.  Mesenchymal Stem Cells: Therapeutic Mechanisms for Stroke.

Authors:  Yuchen Zhang; Naijun Dong; Huanle Hong; Jingxuan Qi; Shibo Zhang; Jiao Wang
Journal:  Int J Mol Sci       Date:  2022-02-25       Impact factor: 5.923

Review 4.  Application of exosomes for the alleviation of COVID-19-related pathologies.

Authors:  Aysa Rezabakhsh; Mahdi Mahdipour; Alireza Nourazarian; Paria Habibollahi; Emel Sokullu; Çigir Biray Avci; Reza Rahbarghazi
Journal:  Cell Biochem Funct       Date:  2022-06-01       Impact factor: 3.963

5.  Ferroptotic MSCs protect mice against sepsis via promoting macrophage efferocytosis.

Authors:  Yuchen Pan; Jingman Li; Jiali Wang; Qi Jiang; Jingjing Yang; Huan Dou; Huaping Liang; Kuanyu Li; Yayi Hou
Journal:  Cell Death Dis       Date:  2022-09-26       Impact factor: 9.685

Review 6.  Cytokine Overproduction and Immune System Dysregulation in alloHSCT and COVID-19 Patients.

Authors:  Andrzej Lange; Janusz Lange; Emilia Jaskuła
Journal:  Front Immunol       Date:  2021-06-02       Impact factor: 7.561

7.  Microfluidic Tools for Enhanced Characterization of Therapeutic Stem Cells and Prediction of Their Potential Antimicrobial Secretome.

Authors:  Pasquale Marrazzo; Valeria Pizzuti; Silvia Zia; Azzurra Sargenti; Daniele Gazzola; Barbara Roda; Laura Bonsi; Francesco Alviano
Journal:  Antibiotics (Basel)       Date:  2021-06-22

Review 8.  Mucormycosis Amid COVID-19 Crisis: Pathogenesis, Diagnosis, and Novel Treatment Strategies to Combat the Spread.

Authors:  Shreya Dogra; Akanksha Arora; Aashni Aggarwal; Gautam Passi; Akanksha Sharma; Gurpal Singh; Ravi P Barnwal
Journal:  Front Microbiol       Date:  2022-01-04       Impact factor: 5.640
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.